• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Schering-Plough

Schering-Plough

Merck & Co Inc MRK

Last Price$63.28Day Change (%)-0.51%
Open Price$63.60Day Change ($)-0.32
Day Range63.16–63.7852-Week Range45.69–64.00

As of Wed 8/24/2016 1:18:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. GCC Countries Anti-Viral Drugs Market Outlook (2016-2021) - Key Players are Abbott, Gilead & GlaxoSmithKline - Research and Markets

    GCC Countries Anti-Viral Drugs Market Outlook (2016-2021) - Key Players are Abbott, Gilead & GlaxoSmithKline - Research and Markets

  2. Biogen Draws Takeover Interest from Rival Drugmakers--2nd Update

    Biogen Draws Takeover Interest from Rival Drugmakers--2nd Update

  3. Biogen Attracts Takeover Interest From Two Rivals

    Biogen Attracts Takeover Interest From Two Rivals

  4. Biogen Draws Takeover Interest from Rival Drugmakers--2nd Update

    Biogen Draws Takeover Interest from Rival Drugmakers--2nd Update

  5. Contrarian Buying at American Funds

    American's managers have been busy buying unloved large caps.

  6. Stockland Profit Slips on One-offs; Strong Gains in Property Business

    Stockland Profit Slips on One-offs; Strong Gains in Property Business

  7. This Pharma Firm Passes the Test

    Positive trial data for diabetes drug Januvia and strong first-quarter results keep Merck's stock undervalued and its wide moat intact.

  8. High-Priced Sale of Consumer Business Strengthens This Big Pharma Firm's Moat

    The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.